Currencies / KURA
KURA: Kura Oncology Inc
6.30
USD
0.14
(2.17%)
KURA exchange rate has changed by -2.17% for today. During the day, the instrument was traded at a low of 6.21 and at a high of 6.55.
Follow Kura Oncology Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KURA News
- Seeking Alpha Kura: Ziftomenib Shift To Newly Diagnosed Mutant AML Patients Bodes Well (NASDAQ:KURA)
- Investing Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US
- Investing Cantor Fitzgerald reiterates overweight rating on Kura Oncology stock
- Investing Kura Oncology stock maintains Overweight rating on AML treatment progress
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing Citizens JMP reiterates Kura Oncology stock rating on positive trial data
- Investing Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB
- Investing Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Investing Kura Oncology at Jefferies Conference: Strategic Advancements in AML
- Investing **citizens jmp reiterates market outperform rating on kura oncology stock**
- Investing Leerink Partners reiterates outperform rating for Kura Oncology stock
- Investing Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock
- Investing Kura Oncology at ASCO: Strategic Moves in AML Treatment
- Investing Kura Oncology reports positive trial results for AML treatment
- Investing H.C. WAINWRIGHT REITERATES BUY RATING ON KURA ONCOLOGY STOCK
- Investing Citizens JMP highlights key ASCO presentations
- Investing Kura Oncology at TD Cowen Summit: Strategic Innovations in Menin Inhibitors
- Investing Cantor Fitzgerald maintains Overweight on Kura Oncology stock
- Investing Kura Oncology to Participate in Three Upcoming Investor Conferences
- Seeking Alpha Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
- Benzinga Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - American Axle & Mfg Hldgs (NYSE:AXL), Alumis (NASDAQ:ALMS)
- Seeking Alpha Kura Oncology: Market Sees A Tough Road Ahead, But There's An Opportunity
- Seeking Alpha Kura Oncology, Inc. (KURA) Q4 2024 Earnings Call Transcript
Daily Range
6.21
6.55
Year Range
5.41
21.57
- Previous Close
- 6.37
- Open
- 6.44
- Bid
- 6.30
- Ask
- 6.60
- Low
- 6.21
- High
- 6.55
- Volume
- 2.574 K
- Daily Change
- -2.17%
- Month Change
- 9.76%
- 6 Months Change
- -18.29%
- Year Change
- -69.40%
31 July, Thursday
11:30
USD
- Act
- Fcst
- Prev
- 47.999 K
11:30
USD
- Act
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Act
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Act
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Act
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Act
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Act
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Act
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Act
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Act
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Act
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Act
- Fcst
- Prev
- 4.245%
15:30
USD
- Act
- Fcst
- Prev
- 4.265%